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G protein-coupled receptors (GPCRs) are the largest class of membrane receptors, playing a
key role in the regulation of processes as varied as neurotransmission and immune response.
Evidence for GPCR oligomerisation has been accumulating that challenges the idea that
GPCRs function solely as monomeric receptors; however, GPCR oligomerisation remains
controversial primarily due to the difﬁculties in comparing evidence from very different
types of structural and dynamic data. Using a combination of single-molecule and ensemble
FRET, double electron–electron resonance spectroscopy, and simulations, we show that
dimerisation of the GPCR neurotensin receptor 1 is regulated by receptor density and is
dynamically tuneable over the physiological range. We propose a “rolling dimer” interface
model in which multiple dimer conformations co-exist and interconvert. These ﬁndings unite
previous seemingly conﬂicting observations, provide a compelling mechanism for regulating
receptor signalling, and act as a guide for future physiological studies.
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G protein-coupled receptors (GPCRs) are the largest classof cell surface receptors forming the target of ~40% ofmarketed pharmaceuticals1. Over the past few decades the
idea that GPCRs function as isolated monomeric receptors has
been challenged by the accumulation of evidence for oligomer-
isation2. It is now widely accepted that constitutive dimerisation
is essential for class C GPCR activity3, and using a variety of
techniques, an array of class A receptors has also been observed to
oligomerise (reviewed by Ferré et al.2). Whilst monomeric GPCRs
can efﬁciently couple to G proteins and recruit arrestin in vitro4,5,
this does not preclude the existence of functional oligomers
in vivo. Indeed, receptor oligomerisation may be required to
trafﬁc receptors to the plasma membrane6, and regulate receptor
internalisation7, but may also affect ligand binding8, and G
protein activation9 suggesting some role for dimerisation in
biased signalling10. Observations of cooperative ligand-binding
have strengthened the case for functional oligomerisation11,
although this interpretation has been challenged by others12.
The controversies surrounding GPCR oligomerisation arise
from apparent inconsistencies in both structural information and
dynamics2. Class A GPCRs lack the large extramembranous
domains that stabilise class C GPCR dimers3, and oligomerisation
has been proposed to occur primarily through transmembrane
(TM) domain interactions12. Given the structural homology of
class A GPCR TM domains, a common dimerisation mechanism
might be envisaged. However, detailed morphological data for
class A GPCR dimers remain largely elusive and are often con-
ﬂicting2, with every receptor transmembrane segment having
been implicated in dimerisation and even studies on the same
receptor proposing different interfaces (Supplementary Table 1).
Although many ensemble methods, including Förster
resonance energy transfer (FRET), cross-linking, and
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Fig. 1 Single-molecule FRET trajectories. FRET a donor and b acceptor single-molecule ﬂuorescence was imaged on a single camera. Single particles were
detected and tracked in time. Images shown here following image processing (see Methods section). In the case of donor trajectories only a sub-fraction
are overlaid for clarity. Scale bar: 5 μm. Two-dimensional diffusion constants were determined for the c donor- and d acceptor-imaged particles: Ddonor
(monomer)= 1.63 μm2 s−1 (95% CI [1.609, 1.647] μm2 s−1, n= 17,853 trajectories); Dacceptor (dimer)= 1.27 μm2 s−1 (95% CI [1.222,1.317] μm2 s−1,
n= 1167 trajectories). Data points represent weighted average at each delay interval over all trajectories. Grey shaded area represents the weighted
standard deviation over all individual trajectory mean squared displacement (MSD) curves. Error bars represent standard error of the mean on each data
point. e, f Sequential frames (30ms per frame) of overlaid donor (green—Cy3) and acceptor (red—Cy5) channels show partial trajectories of monomeric
and dimeric NTS1 species. Scale bar: 5 µm. e Dimer formation: an initial population of Cy3-labelled monomeric NTS1 and dimeric Cy3- and Cy5-labelled
NTS1 diffuse within the membrane. Between frames 3 and 4 a single Cy3-labelled receptor (encircled) switches from green to red indicative of the initiation
of FRET as a result of dimer formation. See also Supplementary Movie 2. f Dimer termination of observation: a FRET capable NTS1 dimer comprised of Cy3-
and Cy5-labelled receptor (encircled) is observed to diffuse in the membrane. Between frames 3 and 4 this spot switches from red to green as FRET is
terminated, either as a result of receptor dissociation or acceptor photobleaching. See also Supplementary Movie 3
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co-immunoprecipitation have suggested GPCRs form constitutive
oligomers2, more recent single-molecule imaging techniques have
revealed transient interactions. Cell-based FRAP studies showed
homodimers of D2 dopamine13 and β1-adrenergic receptors14
were transient on the second timescale, but at expression levels
likely to be well above native. Single-molecule imaging at lower
expression levels of the M1 muscarinic acetylcholine receptor15,
N-formyl peptide receptor16 and β1- and β2-adrenergic recep-
tors17,18 also showed transient dimerisation. However, even in
these experiments, membrane organisation beyond intrinsic
receptor–receptor interactions below the diffraction limit cannot
be ruled out. Although these experiments provide good evidence
for a dynamic equilibrium between GPCR monomer and dimer
populations in vivo, the complexities of the cellular environment
make it very difﬁcult to dissect these isolated observations and
construct a quantitative model of how and why this occurs.
The class A GPCR neurotensin receptor 1 (NTS1) has been
implicated in schizophrenia and Parkinson’s, has been postulated
as a biomarker for various cancers19, and has recently been linked
to obesity20. Its peptide ligand, neurotensin (NT), has a dual role;
it functions as a neurotransmitter in the central nervous system
and as a local hormone in the intestines. NTS1 is also one of a
small number of GPCRs that can be expressed recombinantly in
Escherichia coli21. NTS1 therefore possesses the attractive
combination of being both pharmaceutically important and a
tractable model GPCR. Co-immunoprecipitation of NTS1
demonstrated homodimers in HeLa cells22, but biophysical
characterisation of NTS1 oligomerisation has been limited. At
high receptor densities (~103 μm−2), NTS1 is predominantly
dimeric (~90%) in liposomes21. In solution at low detergent
concentrations, NTS1 dimerisation occurs in a concentration-
dependent manner and dimers show ligand-binding cooperativ-
ity, but catalyse G protein nucleotide exchange with lower afﬁnity
than monomers23.
Here, we combine single molecule and ensemble FRET with
double electron–electron resonance (DEER) spectroscopy and
simulations to study NTS1 dimerisation. Our ﬁndings support a
“rolling interface” model for transient dimerisation in a
concentration-dependent manner that is tuneable over the
physiological range. These ﬁndings are in line with recent obser-
vations for other GPCRs, and rationalise previously incompatible
observations and provide a putative mechanism for regulation of
receptor signalling by dimerisation in vivo, extending the tradi-
tional ligand-dependent view of receptor modulation.
Results
Dynamics of NTS1 dimerisation. To gain insight into dynamics
of NTS1 dimerisation, single-molecule FRET (smFRET) experi-
ments were conducted on receptors ﬂuorescently labelled at the
intracellular end of TM4 (T186C4.42, where the superscript refers
to Ballesteros-Weinstein numbering for GPCRs, see also
Supplementary Fig. 1), which has previously been proposed to sit
at the NTS1 dimerisation interface24. The cysteine depleted
background mutant was shown to bind neurotensin with similar
afﬁnity as wild-type NTS1 (Supplementary Fig. 2), and T186C4.42
labelled with Alexa Fluor 488 (A488) was conﬁrmed to be capable
of interacting with Gαi1 in a GTPγS-dependent manner
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Fig. 2 Single-molecule FRET intensity distributions. The distribution of single particle spot intensities is described well by a single log-normal distribution for
a the predominantly monomeric donor spots (n= 209,712), and c for acceptor spots from a monomeric doubly labelled (TM1–TM4, Cy3–Cy5 distance ~1.5
nm) NTS1 control sample (n= 2816), while for b the FRET acceptor dimer spots it was described by the sum of two log-normal distributions representing
high (dotted line) and low (dashed line) FRET dimeric conformations (n= 8561). Spot lifetime (d–f) was similar for all populations indicating dimer lifetime
on the order of or greater than the photobleaching timescales. Single-step photobleaching (g–i) precludes higher-order oligomers. See also Supplementary
Figs. 6, 7, and 8
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(Supplementary Fig. 3), indicating that the puriﬁed receptor is
functional. Based on the geometry of NTS125,26, the range of
inter-label distances in the NTS1 dimer is expected to fall within
1.5–8 nm regardless of dimer conﬁguration. The Cy3-Cy5 FRET
pair used here has a Förster radius in the middle of this distance
range (R0= 5.4 nm). Labelled receptor was reconstituted into
DPhPC droplet interface bilayers27 (Supplementary Fig. 1) at a
1:4 donor-to-acceptor ratio (see Methods section) and at low
receptor densities (0.43 μm−2) to mimic physiological conditions.
Fluorescence emission from the donor-labelled (Cy3) and
acceptor-labelled (Cy5) NTS1 was imaged using total internal
reﬂection ﬂuorescence (TIRF) microscopy with a temporal reso-
lution of 30 ms. Diffraction-limited diffusive spots were observed
in both the donor and acceptor channels with differing densities,
corresponding to a majority population of monomeric protein
and a smaller sub-population of FRET capable putative dimers
(Fig. 1a, b and Supplementary Movie 1). In superimposed donor
and acceptor videos, individual spots could be observed to tran-
sition from donor to acceptor and acceptor to donor (Fig. 1e, f)
consistent with dimer formation and dissociation or acceptor
photobleaching, respectively.
Two-dimensional diffusion constants were determined from
the mean squared displacement of single trajectories in both the
donor and acceptor channel (Fig. 1c, d). NTS1 molecules
observed in the acceptor channel (i.e., dimers, Dacceptor= 1.27
μm2 s−1, 95% conﬁdence interval (CI) [1.222,1.317] μm2 s−1, n=
1167 trajectories) diffused signiﬁcantly more slowly than those in
the donor channel (i.e., monomers, Ddonor= 1.63 μm2 s−1, 95%
CI [1.609,1.647] μm2 s−1, n= 17,853 trajectories) as gauged by a
two-sided z-test (z=−14.12, p < 10−5). Using the Saffman-
Delbrück model for lateral diffusion (D∝-ln[r]), this is suggestive
of an 1.4-fold increase in the effective particle radius (r),
supporting the assignment of acceptor spots as dimers28. The
spot intensity distribution in both the donor and acceptor
channel broadly ﬁtted a lognormal distribution29 with single-step
photobleaching (Fig. 2), characteristic of single molecules.
The relative number of donor and acceptor spots provides a
snapshot of the equilibrium monomer-dimer distribution (Supple-
mentary Fig. 4). The frequency of observation of dimeric species fell
sharply with decreasing receptor density (Supplementary Fig. 4a).
After correcting for labelling efﬁciency (see Supplementary Note 1)
we ﬁnd that, on average, 9.8% of all receptors exist as dimers at a
receptor density of 0.43 molecules per μm2. False positive
dimerisation detection due to co-diffusing, non-interacting mono-
mers was quantiﬁed to be negligible (0.04%, Supplementary Note 2,
and Supplementary Fig. 5). The frequency of observed dimerisation
events decreased with time due to photobleaching of the donor
population (Fig. 3a, b). The dimerisation rate constant was
determined by extrapolation of the observed frequency of dimer
formation to t= 0 s giving the rate of dimer formation in the
absence of photobleaching (Fig. 3a and Supplementary Note 1).
Following correction for labelling ratio we calculate a dimerisation
kon of 0.081 μm−2 s−1 (95% CI [0.072,0.088] μm−2 s−1,
Supplementary Note 1–4). Spot lifetime (Fig. 2d–f) was similar
for all populations, indicating dimer lifetime largely on the order of,
or greater than, the photobleaching timescales. Whilst this
precluded accurate direct measurement of dimer lifetime, this
could be calculated using the kon and the measured equilibrium
between monomer and dimers (i.e. 9.8% dimers), giving a dimer
half-life of t1/2= 1.2 s, (95% CI [0.65,1.54] s).
Concentration-dependence of dimerisation. Due to the inherent
limitations of single-molecule and ensemble techniques, an
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Fig. 3 Dynamics of dimer population. a Experimental data: rate of Cy3–Cy5 dimer formation as observed by the formation of new acceptor trajectories
(n= 19 videos). The observed frequency of dimer formation decreases with time due to photobleaching. Exponential ﬁtted model (blue line) enables
extrapolation to zero photobleaching and subsequent calculation of total dimer formation rate. b Experimental absolute frequency of observed dimer
formation events. c The dimeric population observed during Monte Carlo simulations at different protein density parameterised by measured single-
molecule receptor dynamics is shown. Simulations at the receptor density used in single-molecule experiments correlate well with experimental
observations (red dot), and ensemble FRET measurements from previous studies at four orders of magnitude higher receptor density (blue dot). Blue
shaded area highlights the reported physiological range of average cell surface receptor densities for NTS1 (2–40 μm−2)45. d Monte Carlo simulation of
single-molecule experimental conditions of receptor density and number of receptors (see also Supplementary Movie 4). Dynamic equilibrium illustrates
ﬂuctuation of monomer and dimer populations over the experimental timescale, explaining the observed variance in dimer formation (a, b) and dynamic
equilibrium monomer-dimer distribution (c—red spot error bars, see also Supplementary Fig. 4)
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intermediate protein surface density regime remains inaccessible
to either method. Complementary Monte Carlo (MC) simulations
were employed to bridge this concentration gap. An estimated
mean monomer–monomer collision frequency of ~0.31 collisions
μm−2 s−1 was calculated from the experimentally determined
diffusion rates, and protein surface densities, assuming a particle
radius of 2.5 nm (see Supplementary Note 3 and Supplementary
Movie 4)30. With the experimentally observed dimer formation
rate of 0.081 μm−2 s−1 (Fig. 3a), this means that ~20% of all
monomer–monomer collisions result in dimerisation. Using the
experimental diffusion coefﬁcients, the diffusion of monomers at
speciﬁc surface densities was simulated, ascribing a 20%
probability, based on the estimate of dimerisation collision
efﬁciency, that any random collision (collision diameter <5 nm)
would result in dimer formation, upon which the monomers were
replaced with a single dimer particle in the simulation. Following
dimer formation, our experimental koff (0.58 s−1, 95% CI
[0.45,1.07] s−1) was used to determine the probability of a dimer
dissociating back into two monomers. Each simulation was run
until dynamic equilibrium and the proportion of dimers relative
to the total receptor concentration was determined. The
measured dimer population observed in the smFRET experiments
could be reproduced in the MC simulations (Fig. 3c, d and
Supplementary Fig. 4). At protein densities of ≥103 μm−2,
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Donor (green) and acceptor (red) channels together with their overlay (registered to nearest pixel) show temporal ﬂuctuation in FRET in the dimer species
(note, relative contrast is set to illustrate both channels in overlay). Scale bar: 5 μm. See also Supplementary Movie 5. b Representative NTS1 dimer
ﬂuorescence traces (green: donor, red: acceptor, see also Supplementary Fig. 9) illustrate temporal ﬂuctuation within a single dimer trajectory; donor and
acceptor ﬂuorescence intensities are anti-correlated. c FRET efﬁciency histogram from 40 dimer trajectories shows a broad distribution of FRET efﬁciencies
consistent with high and lower acceptor ﬂuorescence intensity populations, suggesting multiple dimerisation interfaces. d Fluorescence intensity of the
acceptor in a dimer species is shown for a single dimer trajectory (see also Supplementary Fig. 8). A bimodal acceptor ﬂuorescence intensity distribution,
showing high- and low-FRET states, was measured for NTS1 dimers in single-molecule experiments (Fig. 2b and Supplementary Fig. 8). Rather than
observing dimer trajectories with acceptor ﬂuorescence intensities at either low or high levels, the acceptor ﬂuorescence intensity showed changes within
trajectories, suggesting that the bimodal acceptor ﬂuorescence intensity distribution (Fig. 2b) is a result of dynamic interconversion between different
dimerisation interfaces. Interconversion between high- and low-FRET states was analysed. A conservative threshold was deﬁned (166.5 counts—grey
dashed line in d, see also Supplementary Fig. 8), above which intensities have <1% probability of belonging to the low-FRET state. e Lifetime measurements
above and below this threshold show dimers exhibiting higher propensity for greater dwell-times in low-FRET (top panel) than in high-FRET (bottom panel)
conﬁgurations, in keeping with the relative mixing proportions of the two component intensity distributions and FRET efﬁciency distribution. The lifetime of
the low-FRET state is dependent upon it being an initial, mid-, or ﬁnal transitional state, which could be suggestive of two or more low-FRET states
exhibiting differing stability, with the capability to interconvert via a high-FRET state
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simulated dimeric populations of ~86%–90% are predicted, in
agreement with those observed in earlier ensemble FRET
experiments on NTS1 (~89%)21. It is also notable that dimer-
isation events become increasingly rare during simulations below
receptor densities that might be expected in vivo (Fig. 3c), in
agreement with our experimental results (Supplementary Fig. 4a).
This observation may provide an explanation for conﬂicting
reports on GPCR dimerisation in different systems.
Dimerisation interface. The receptor interface at which the
monomer–monomer collisions occur was not speciﬁcally taken
into account in the MC simulations, although its effect is likely to
be accounted for in the collision efﬁciency of 20% estimated from
the experimental observations. A simple model in which the
receptor has four distinct faces with only one combination of
these compatible with dimerisation would yield an expected
maximum dimerisation probability of ~6% in the event that all of
these collisions would be productive, which is unlikely. The
higher dimerisation efﬁciency observed suggests that the interface
of dimerisation is likely to be less stringently deﬁned than a single
productive interface.
Indeed, a multimodal ﬂuorescence intensity distribution repre-
senting high- and low-FRET states was observed for the acceptor
intensity in NTS1 FRET dimers in the single-molecule experiments
(Fig. 2b), consistent with multiple dimeric states. To quantify this, a
Gaussian mixture model containing one to four components was
ﬁtted to the logarithm of the intensity distribution and the relatively
likelihood of each model was assessed from the Bayesian
information criterion (BIC) value of each model, where higher
BIC values indicate more probable models (Supplementary Fig. 6).
The intensity distribution of the acceptor FRET spots was not well
described by a single component, in contrast to the intensity
distribution of the donor (Fig. 2a and Supplementary Fig. 6i); a two-
or three-component model, representing a combination of high and
lower energy transfer states, described the intensity distribution of
the acceptor FRET spots better than the single component model
(Supplementary Figs. 6g and 7). The acceptor intensity distribution
of a control sample in which NTS1 monomers were doubly labelled
with Cy3 and Cy5 to measure intramonomer FRET (Fig. 2c) was
well described by a single component (Supplementary Fig. 6h),
suggesting that the observation of multiple components in the
acceptor intensity distribution of the dimeric species (Fig. 2a) is the
result of at least two populations with different dimer conﬁguration
with distinguishable acceptor intensities (i.e., FRET efﬁciencies).
To determine the nature of these populations, the dimer
acceptor trajectory intensities were analysed (Fig. 4 and
Supplementary Note 6) in order to categorise dimers as belonging
to either high- or low-FRET dimer conﬁgurations. The acceptor
intensity distribution was equally compatible with a two- and
three-component model (Supplementary Fig. 6g), with one high
and either one or two lower energy transfer populations,
respectively (Supplementary Fig. 7). Here, the simplest two-
state model was chosen in order to aid assignment of the acceptor
intensity to a speciﬁc subpopulation. A conservative intensity
threshold was deﬁned to describe the high acceptor intensity state
(Fig. 4d, Supplementary Fig. 8, and Supplementary Note 6), above
which intensities had <1% probability of belonging to the low-
FRET state population. Rather than observing the presence of two
distinct trajectory intensity populations, the minor high-FRET
component was found to originate from short-lived ﬂuctuations
in acceptor intensity (i.e., threshold crossing, Fig. 4d, and
Supplementary Fig. 8). Anti-correlated donor and acceptor
intensities from dimer trajectories (Fig. 4b, and Supplementary
Fig. 9) illustrated rapid temporal ﬂuctuations that could also be
observed in overlaid two-colour image sequences (Fig. 4a and
Supplementary Movie 5). Within the overall FRET efﬁciency
distribution (Fig. 4c) the contribution of high FRET efﬁciency
observations (E > 0.9) was 20.4%, in close agreement with the 16%
fractional contribution attributed to high acceptor intensity states
in the acceptor intensity distribution (Fig. 2b).
Dimer acceptor trajectories were analysed for threshold
crossing and dwell-time in high- and low-intensity states was
extracted (Fig. 4e). Dimers exhibited greater dwell-time in low-
intensity conformation states, in keeping with the relative mixing
proportions of the two-component distribution, indicative of a
more stable lower intensity state with brief forays into a higher-
FRET conformation. Cumulative lifetime probability of low-
FRET states reveals an apparent divergence of dwell-time in the
low-FRET state dependent upon whether this low-state con-
formation is adopted as the initial, mid-, or ﬁnal recorded
transition of the dimer trajectory (Fig. 4e, top panel). This
observation could be explained by the presence of two or more
low-FRET states of differing stability and propensity of formation
capable of interconversion via a high-FRET state intermediate
(Supplementary Note 6).
To further probe the dimerisation interface, NTS1 was singly
labelled with spin labels (for DEER) or ﬂuorescent probes (for
ensemble FRET) at the intracellular end of each TM and H8
(speciﬁcally residues 901.58, 1042.41, 1723.55, 1864.42, 2615.52,
3076.34, 3717.55, and 3788.52, see Supplementary Fig. 1) and
reconstituted in brain polar lipid (BPL) liposomes. Intradimer
distances were probed between corresponding TMs in each
protomer (i.e., TM1–TM1, TM2–TM2 etc.), to assess the relative
proximity of each TM to the dimerisation interface.
DEER revealed broad distance probability distributions span-
ning ~4 nm with multiple peaks for all intradimer TM–TM
distances (Fig. 5 and Supplementary Fig. 10), unlikely to be solely
due to the conformational spread of the spin label tethers,
Table 1 Ensemble interprotomer FRET
TM/H (residue) Ecor(apo) n Ecor(+NT) n (ΔEcor) Pr(ΔEcor > 0)
1 (A90C1.58) 0.73 ± 0.03 13 0.77 ± 0.04 9 −0.038 0.73
2 (Y104C2.41) 0.9 ± 0.1 6 0.9 ± 0.1 6 0.054 0.40
3 (C1723.55) 1.03 ± 0.05 5 1.02 ± 0.02 5 0.0056 0.49
4 (T186C4.42) 0.77 ± 0.03 13 0.78 ± 0.04 13 −0.010 0.57
5 (A261C5.52) 0.98 ± 0.06 6 1.05 ± 0.09 6 −0.073 0.70
6 (V307C6.34) 0.99 ± 0.04 11 0.82 ± 0.04 11 0.17 0.99
7 (L371C7.55) 0.68 ± 0.07 6 0.7 ± 0.1 6 −0.073 0.67
8 (Q378C8.52) 0.89 ± 0.02 8 0.89 ± 0.02 8 0.0047 0.43
The mean corrected FRET efﬁciency (Ecor) for n replicate experiments, and standard error of the mean are given for NTS1 labelled on TM1–7 or H8 reconstituted in brain polar lipid liposomes with (+NT)
or without (apo) 5 μM agonist neurotensin. The difference between the mean corrected FRET efﬁciency for the receptor in the presence and absence of agonist (ΔEcor), and the probability (Pr) that ΔEcor
is larger than zero is given
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suggestive of multiple dimer conﬁgurations, in agreement with
the smFRET data (Fig. 4 and Supplementary Fig. 6).
Interprotomer resonance energy transfer efﬁciencies (Ecor) from
complementary ensemble FRET experiments are given in Table 1.
The average TM4–TM4 Ecor of 0.77 ± 0.03 (Table 1) corresponds to
an inter-label distance of 5.7 ± 0.3 nm (assuming κ2= 2/3, and
using R0= 7.0 nm for the Förster radius of the A488–A555 donor
and acceptor pair31), which agrees well with the TM4-4 inter-
monomer distance estimated from smFRET (~5 nm, see Supple-
mentary Note 5 and Supplementary Fig. 11). Additionally,
statistically signiﬁcantly lower transfer efﬁciencies (i.e., longer
distances) were found for NTS1 labelled on TM1, 4, and 7
compared to TM2, 3, 5, 6, and H8 (Table 1 and Supplementary
Table 2). Although the IC ends of TM1 and 7 are indeed in close
proximity in the NTS1 protomer (Supplementary Fig. 1) and
similar FRET efﬁciencies can therefore be expected for labels on
these positions, the IC ends of, e.g., TM2 or H8 and TM5 or 6 are
on the opposite sides of the molecule, and the observation of high
FRET efﬁciency for labels at all of these
sites does not appear consistent with a single dimerisation interface.
While this discrepancy could in part be explained by the ﬂexible
linkers attaching the ﬂuorophores (~1.5 nm), it could also be the
result of an ensemble of dimer interfaces where different groups of
TM helices can be present at the interface in different dimer
conﬁgurations, consistent with the smFRET and DEER results.
Taken together, these ﬁndings provide strong evidence that
NTS1 dimers explore a number of metastable interfaces. To
identify interfaces compatible with the experimental observations,
structural NTS1 dimer models were constructed representing four
different classes of interfaces observed in GPCR crystal structures
comprising: (1) TM1–2–H8 (ß1AR, PDB 4GPO; µOR, PDB
4DKL; and κOR, PDB 4DJH); (2) TM3–4 (H1R, PDB 3RZE); (3)
TM3–4–5 (CXCR4, PDB 3OE0; and ß1AR, PDB 4GPO); and (4)
TM5–6 (µOR, PDB 4DKL, Supplementary Fig. 12)32–36. All seven
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dimerisation interfaces were stable during 10 μs coarse grained
(CG) simulations in BPL-like bilayers (see Methods section), and
are consistent with earlier proposed GPCR oligomerisation
models based on competition studies with synthetic peptides37,
cross-linking experiments38, and CG simulations39 (Supplemen-
tary Table 1).
The CG simulation frames for the seven dimer interface models
were converted back to atomistic representation40. The inter-
residue distances along the trajectories were measured for all
labelling sites used in the ensemble FRET and DEER measure-
ments, and the corresponding average estimated FRET efﬁciencies
were calculated for each labelling site for each model. Given the
evidence supporting multiple NTS1 dimer interfaces, the resulting
estimated average FRET efﬁciencies for all possible linear
combinations of these interface models (including between one
and all seven models) were compared to the experimental
FRET results, using least-squares optimisation (see Methods
section). The relative likelihood of the different combinatory
models was assessed from the ﬁt residuals (RSS) and the Akaike
information criterion (AIC) value of each model (Supplementary
Table 3).
A combination of a TM5–6 interface with a small fractional
contribution (f) of either a TM3–4 (f56= 0.8 ± 0.3, and f34= 0.2 ±
0.3, respectively) or a TM1–2–H8 (f56= 0.9 ± 0.2, and f128= 0.1 ±
0.2, respectively) interface gave the best two-component ﬁt to the
experimental ensemble FRET results (Fig. 5a–c, Supplementary
Table 3). A combination of these three interfaces (f56= 0.8 ± 0.3, f34
= 0.04 ± 0.4, and f128= 0.1 ± 0.6) produced a better ﬁt (i.e., lower
RSS), but was a less probable model based on its higher AIC value
(Supplementary Table 3). A single-component model with either a
TM5–6 interface, or a TM3–4 interface produced a worse ﬁt (i.e.,
higher RSS), but was equally probable based on AIC as the two-
component models (Supplementary Table 3). Thus, in agreement
with the evidence from smFRET and DEER, a combination of these
dimerisation interfaces would be most probable (Fig. 2a, and
Supplementary Fig. 6).
Theoretical DEER distance distributions were calculated for the
three dimer models (Fig. 5e, shaded histograms), taking into
account the conformational spread of the spin labels (see
Supplementary Fig. 1); the individual predicted distance distribu-
tions for each of the models show partial overlap with different
peaks in the experimental distance distributions (Fig. 5e, solid
black line). The calculated distance distributions were compared
to the experimental DEER results, using least-squares optimisa-
tion, and the RSS and AIC of the different model combinations
compared to the experimental DEER data are given in
Supplementary Table 4. A linear combination of two or three
models gave signiﬁcantly lower AIC values than any of the
individual models. Thus, a combination of multiple interface
models is consistent with the observation of both short and long
distances for most of the inter-TM DEER measurements, with the
combined predicted distance distribution covering most of the
experimentally observed distances (Fig. 5). However, the relative
contributions of the different peaks in the DEER distance
distribution, and thus the relative contribution of the
different models obtained from the ﬁts, cannot reliably be
interpreted, since the probability for longer distances (>5 nm)
cannot accurately be determined from the relatively short DEER
traces (Supplementary Fig. 10) suffering from strong relaxation
due to the two-dimensional distribution of the spin labels in the
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lipid bilayers. The average inter-protomer Cß–Cß distances for the
TM4 residue (1684.42) labelled in the smFRET experiments, from
simulations for the TM5–6 model (4.6 ± 0.1 nm) and the TM3–4
model (1.5 ± 0.2 nm), agree well with the estimated average
distances of the low- and high-FRET populations observed in the
smFRET experiments, with similar relative fractional contribu-
tions (flow= 0.84, fhigh= 0.16). The TM1–2–H8 interface model
showed a longer average Cß–Cß distance (5.3 ± 0.2 nm) for residue
1684.42 in the simulations, and is thus unlikely to represent the
minor high-FRET population observed in the smFRET experi-
ments (Fig. 5e), but could contribute to the major low-FRET
population.
Ligand modulation of dimerisation interface. Addition of
saturating amounts of agonist (NT, 5 μM) had only a statistically
signiﬁcant effect on the FRET efﬁciency observed for TM6, where
NT showed a 99% probability of decreasing Ecor (Table 1 and
Supplementary Table 2), reﬂecting an increase in the inter-TM6
distance in the dimer. Considering the consensus that TM6
undergoes the largest conformational change upon GPCR acti-
vation and G protein coupling41, it is possible that the observed
agonist-induced change in Ecor is due to a conformational change
in TM6 of the protomers in the dimer as typically observed in the
monomer, with the conformational change giving rise to the
change in Ecor directly, and/or indirectly by promoting a change
in the preferred dimerisation interface. Although the physiolo-
gical signiﬁcance of NTS1 homodimerisation has not yet been
studied in vivo, the observation that agonist can elicit a con-
formational change of TM6 in the dimer as in the monomer
suggest that certain conformations of dimers could be signalling
competent. Alignment of the activated G protein-coupled struc-
ture of the β2-adrenergic receptor (PDB 3SN641) to the NTS1
dimer models (Fig. 6) suggests that the TM5–6 dimer interface,
which is most consistent with the ensemble data for the apo
receptor, is not compatible with the canonical outward movement
of TM5 and 6 upon receptor activation, thus precluding receptor
activation, as previously discussed33. Conversely, the TM3–4 or
the TM1–2–H8 dimer interface models could support G protein
activation. As for the apo receptor, the best ﬁt of the MD dimer
models to the FRET efﬁciency in the presence of agonist was
obtained with a combination of the TM5–6 and TM3–4 interface
models (Fig. 5a, b, and Supplementary Table 3). However, a slight
decrease in fractional contribution of the TM5–6 interface was
found (f56= 0.7 ± 0.3, and f34= 0.3 ± 0.3 in the presence of ago-
nist compared to f56= 0.8 ± 0.3, and f34= 0.2 ± 0.3 for the apo
dimer), and shown to be statistically signiﬁcant by an F-test,
suggesting that receptor activation could lead to a change in the
dimerisation interface, possibly promoted by the outward
movement of TM6 (Fig. 6). However, it must be noted that the
models used represent the inactive state of the receptor and the
receptor in an active conformation may yield dimer interfaces not
included in the present study.
Discussion
Homo- and heterodimerisation of GPCRs has increasingly been
associated with altered signalling proﬁles2. NTS1 homo-
dimerisation has thus far not been studied in vivo, but has been
shown to lower the afﬁnity of G protein nucleotide exchange
in vitro, while NTS1 heterodimerisation has been shown to
modulate G protein selectivity42 and has been implicated in lung
cancer cell growth43. However, the mechanisms through which
dimerisation modulates NTS1 function remain unclear.
In agreement with recent observations for other GPCRs23, the
data presented here support the notion of a dynamic transient
NTS1 dimer with a half-life (t1/2= 1.2 s) consistent with previous
reports on other receptors (~0.1–5 s)15–17. Interestingly,
NTS1 showed a lower oligomeric population of 9.8% compared to
~30–60% reported previously at similar receptor densities
(~0.5–2 μm−2) for other GPCRs15–17. This may reﬂect receptor
type-dependent differences in dimerisation propensities, but may
also be due to differences in experimental conditions; previous
single-molecule studies of GPCR oligomerisation dynamics have
relied on co-localisation and stepwise photobleaching, which may
also interpret protomer crowding as oligomerisation15–17. Here,
by using FRET, we are sensitive to monomer separations 10-fold
smaller than distinguishable with the previously employed
methods, and can thus more reliably determine bona ﬁde
protein–protein interactions. Furthermore, here, intrinsic
receptor–receptor interactions are being characterised, unper-
turbed by additional cellular interactions, suggesting that
dimerisation is an inherent property of NTS1, which may be
driven by hydrophobic mismatch as has been proposed for other
GPCRs44, and the extent of which may be modulated by the
cellular environment. The observed Kd for NTS1 dimer formation
of 7.1 μm−2 (95% CI [6.7,12.3] µm−2, Supplementary Note 1) lies
within the reported physiological range of average cell surface
receptor densities (2–40 μm−2)45. Thus, possible sequestration
(whether temporal or constitutive) of NTS1, leading to changes in
local concentrations, would dramatically alter dimerisation rates
on the sub-second timescale, with potentially functional impli-
cations. Indeed, clustering of GPCRs in microdomains has pre-
viously been reported to affect GPCR dimerisation and
signalling46.
While NTS1 reconstitution in liposomes has previously been
shown to yield symmetric reconstitution with ~50/50 distribution
of both orientations21, the reconstitution orientation in the droplet
interface bilayers used in the smFRET experiments is unknown.
Symmetric reconstitution would at most halve the effective protein
density, since each receptor will only be able to interact with half
of the receptors present, resulting in an underestimation of the
dimer half-life, t1/2= 1.2 s, (95% CI [0.65,1.54] s), and the Kd=
7.1 µm−2 (95% CI [6.7,12.3] µm−2) by a factor of two. Whilst we
cannot exclude symmetric reconstitution, or the formation of non-
physiological antiparallel dimers in our experimental system, the
observed dimer half-life (1.2 s) is consistent with previous reports
on other GPCR dimers (~0.1–5 s)15–17. Furthermore, the inter-
label distance in the high-FRET state is too short to originate from
an antiparallel dimer, and high- and low-FRET states were
observed to interconvert (Fig. 4), precluding that antiparallel
dimers contribute to the measured smFRET. Thus, the effect of
reconstitution orientation on our results is expected to be modest
(see also Supplementary Note 7).
To our knowledge, here, we demonstrate the ﬁrst evidence for a
GPCR dimer “rolling interface” in which monomers sample a
number of different conﬁgurations that can interconvert during
the dimer lifetime by rotation of the monomers relative to each
other. Many GPCR dimers have been proposed to adopt a variety
of (conﬂicting) conﬁgurations using different approaches with
most, if not all, TM domains having been implicated in the
interaction interface (see Supplementary Table 1). The rolling
interface model accommodates these previously contradictory
ﬁndings as a consequence of the dynamic nature of the dimer
interface, whilst demonstrating that a number of preferred
arrangements exist. Although multiple dimerisation interfaces
could also lead to the formation of higher-order oligomers as
observed for other GPCRs17, higher-order oligomers were pre-
viously excluded for NTS1 in this experimental ensemble system
(at ~1–3 × 103 µm−2)21 and are not detected here at the single-
molecule level at much lower densities (~0.4 µm−2), with MC
simulations unifying these conditions (Fig. 3c). However, for-
mation of higher-order oligomers at even higher protein densities
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(>104 µm−2) well above average physiological expression levels
cannot be excluded.
The possibility of multiple dimer interfaces has been previously
proposed based mainly on evidence from cross-linking
studies47,48, and is in line with recent computational
work39,49,50. Changes in the dimerisation interface have pre-
viously been shown to be linked to receptor activation48,50. Here,
we extend the model, showing that apo NTS1 forms a metastable
dimer, which samples multiple dimer conﬁgurations with distinct
dimerisation interfaces with varying stability on a per molecule
basis. Given the sequence similarity with other GPCRs in the TM
domain, and previous observation of multiple dimerisation
interfaces for both class A and C GPCRs, the “rolling interface”
model may also hold for other receptors in the superfamily. At a
physiological level, the presence of a number of metastable
interfaces increases the likelihood of dimer formation through
random collisions. Furthermore, the functional consequence of
dimerisation may depend on the interface involved in the asso-
ciation, and dynamic reorientation of the dimerisation interface
provides an increased level of biological complexity, which could
play a role in biased signalling or other forms of allosteric reg-
ulation. Indeed, heterodimerisation of the κ-opioid receptor with
NTS1 biased its signalling toward the β-arrestin pathway42. The
dimer conﬁguration may inﬂuence the ability of the protomers to
undergo conformational changes associated with G protein sig-
nalling as suggested by different dimer models (Fig. 6). Our
ﬁndings, as well as previous cross-linking7,38 and computational
studies39, suggest that the activation state of the receptor affects
the preferred dimerisation interface. Here, apo NTS1 appears to
favour a TM5-6 interface that is incompatible with G protein
coupling. It is thus tempting to speculate that dimerisation might
also have evolved as a mechanism to increase the ﬁdelity of GPCR
signalling by lowering basal signalling in the absence of agonist
stimulus. Such a mechanism would be consistent with the pre-
viously reported very low basal signalling of NTS151, and the
lower potential of NTS1 dimers compared to monomers to cat-
alyse G protein nucleotide exchange in detergent23. Alternatively,
intradimer interactions may affect the conformation of the pro-
tomers, which in turn may affect G protein signalling properties
including speciﬁcity52.
It has to be noted that the relevance of the crystallographic
dimers used here as templates for speciﬁc dimerisation interfaces is
contentious. Indeed, many GPCRs have also been crystallised in
antiparallel “dimeric” conﬁgurations. Nevertheless, in the absence
of other high-resolution structural information on GPCR dimers,
the energetically favourable parallel interfaces observed in crystal-
lography may represent viable models of dimerisation interfaces
in vivo, although other, including asymmetric interfaces, may exist.
As previously argued, e.g., by Bouvier and Hebert53, transience
of dimerisation as observed here for NTS1 and previously for
other GPCRs13–18 does not preclude any role in modulation of
signal transduction, and may in fact be an important feature of its
role in signal regulation. GPCRs show complex signalling pat-
terns, activating different G proteins as well as arrestins, requiring
signiﬁcant conformational plasticity. A combination of multiple
dimerisation interfaces and concentration-dependence of dimer-
isation could provide an attractive speculative mechanism for
cells to dynamically inﬂuence signalling cascades rapidly and in a
temporally and spatially regulated manner, e.g., through stabili-
sation of particular dimer interfaces by the local lipid environ-
ment49 or through modulation of receptor density governing
dimer fraction. This could have broader implications for regula-
tion of GPCR signalling, extending the traditional ligand-
dependent view of functional selectivity to incorporate direct
contributions from allosteric receptor–receptor interactions,
analogous to the effect of RAMPs on Class B GPCRs54.
Modulation of dimer lifetime, preferred interface, or interface
interconversion with possible implications for signalling could
occur endogeneously, e.g., through the lipid environment39,49, or
by exogenous compounds. Indeed, it has been demonstrated that
a variety of GPCRs, including NTS1, are aberrantly overexpressed
in cancerous cells19,55 and, as such, can be envisaged to possess
altered dimerisation and signalling proﬁles in disease states,
making the dimerisation interface a potential drug target.
In conclusion, this study provides compelling evidence that
NTS1 dimers are a dynamic species which can explore multiple
interfaces and contributes to a growing body of work suggesting
that class A GPCR dimerisation can be transient and con-
centration-dependent, providing an explanation for previously
conﬂicting reports on GPCR dimerisation interfaces or dimer-
isation propensity in different experimental systems. While the
exact physiological role of dimerisation is still unknown, a better
understanding of its physical and temporal nature will inform
future functional studies.
Methods
Production and liposome reconstitution of labelled NTS1. Single mutations
were introduced into a Cys-depleted background mutant of rat NTS1 (C172S3.55,
C278SIC3, C332S6.59, C386SC-term, and C388SC-term) using the QuikChange II
protocol (Stratagene): A90C1.58 (TM1), Y104C2.41 (TM2), S(C)172C3.55 (TM3, re-
introduced native Cys), T186C4.42 (TM4), A261C5.52 (TM5), V307C6.34 (TM6),
L371C7.55 (TM7), and Q378C8.52 (H8). Primer sequences are shown in Supple-
mentary Table 5. Labelling sites were chosen based upon homologous sites pre-
viously employed in a site-directed spin labelling study of rhodopsin56. Microscale
thermophoresis measurements were performed to test ligand and G protein
binding to the (labelled) NTS1 cysteine mutants (see Supplementary Note 8). NTS1
was expressed in E. coli BL21(DE3) (competent cells purchased from Agilent
Technologies), as a fusion construct NTS1BH6 (MBP-TEV-rT43NTS1-His6-TEV-
TrxA-His10), where NTS1 is truncated at the N-terminus (1–42), has a hexa-His-
tag added to its C-terminus, and is ﬂanked by TEV protease recognition sites
separating it from its N- and C-terminal fusion partners, maltose binding protein
and thioredoxin, respectively, followed by an additional C-terminal deca-His-tag.
Starter cultures (5–7.5 mL LB, 1% (w/v) glucose, 100 µg/mL ampicillin) were
inoculated with a single colony of NTS1BH6 plasmid-transformed E. coli BL21
(DE3) each, and incubated overnight at 37 °C and 200 rpm. In 2 L conical ﬂasks,
aliquots of 500 mL 2xYT medium supplemented with 0.2% glucose, and 100 μg mL
−1 ampicillin were inoculated with 5 mL of starter culture each, and incubated at
37 °C at 200 rpm, usually growing 10–20 L of culture at a time. When the cultures
reached an OD600 of 0.3 the temperature was decreased to 26 °C, until the cultures
reached an OD600 of 0.5, at which point expression was induced by addition of
IPTG to a ﬁnal concentration of 0.25 mM. Cells were harvested by centrifugation
(7000 g, 4 °C, 15 min) after overnight expression and either solubilised directly or
ﬂash-frozen in liquid nitrogen and stored at −80 °C. NTS1BH6 was puriﬁed by
immobilised metal afﬁnity and ligand afﬁnity chromatography. All puriﬁcation
steps were carried out at 4 °C unless stated otherwise. Speciﬁcally, cell pellet was
resuspended in 2 mL per gram of cell pellet 2 × solubilisation buffer (100 mM Tris
pH 7.4, 400 mM NaCl, 60% glycerol) supplemented with protease inhibitors (2 μg
mL−1 leupeptin, 2 μg mL−1 pepstatin A, and 3 µg mL−1 aprotinin). Cells were
incubated for 20 min with 1 mg of DNase I and 1 mgmL−1 lysozyme, and sub-
sequently lysed using a French press, passing cells 2–3 times through the press at 16
kpsi. DDM, CHAPS (both Melford) and CHS (Sigma-Aldrich) were added drop-
wise to the lysate under stirring to a ﬁnal concentration of 1%, 0.5%, and 0.1% (w/
v), respectively. MilliQ H2O was added to give a ﬁnal volume of 4 mL per gram of
pellet, and the cells were left to stir for 6 h. Unsolubilised material was pelleted by
centrifugation (70,000 g, 4 °C, 60 min). The solubilised fraction (supernatant) was
ﬁltered through a 0.2 µm syringe ﬁlter and imidazole (Merck) was added to a ﬁnal
concentration of 50 mM, before loading the sample onto a freshly charged, 5 mL
HisTrap HP column (GE Healthcare), pre-equilibrated with NiA buffer (50 mM
Tris-HCl pH 7.4, 200 mM NaCl, 10% glycerol (v/v), 0.5% CHAPS (w/v), 0.1%
DDM (w/v), 0.1% CHS (w/v), 50 mM imidazole, protease inhibitors). The column
was washed with 35–40 CV of NiA buffer and the protein was eluted with NiA
buffer supplemented with 500 mM imidazole. A280 was monitored, the peak
fractions were pooled, and the fusion partners were removed by incubation with
TEV protease (produced in-house) at a 1:1 molar ratio and 5 mM DTT for ~16 h,
at 4 °C. NTS1 was then diluted ﬁve-fold with NT0 buffer (50 mM Tris pH 7.4, 10%
glycerol, 0.1% DDM (w/v), 0.01% CHS (w/v)) to reduce the NaCl concentration
and further puriﬁed by ligand afﬁnity chromatography on an NT column, using N-
terminally Cys-derived NT (Alta Bioscience) immobilised on Ultralink iodoacetyl
resin (Pierce, Thermo Scientiﬁc), ensuring the ﬁnal sample contained only properly
folded receptor, capable of ligand binding. Speciﬁcally, the diluted nickel column
eluate was incubated with approximately 1–2 mL of resin for 2–3 h at 4 °C on a
rotating wheel. NT resin was washed with 50–70 CV of NT70 buffer (70 mM
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03727-6
10 NATURE COMMUNICATIONS |  (2018) 9:1710 | DOI: 10.1038/s41467-018-03727-6 |www.nature.com/naturecommunications
NaCl), followed by a 50 CV wash with NT150 buffer (150 mM NaCl), after which
the sample was eluted with NT1 buffer (1M NaCl) and supplemented with 5 mM
DTT. NT column eluate was concentrated by combining several batches on a 1 mL
HisTrap HP nickel column (GE Healthcare). The sample was loaded onto the
column at 0.5–1 mLmin−1. Flow-through was collected and re-applied to the
column. The column was washed with 100 CV NiA0 buffer (50 mM Tris-HCl pH
7.4, 200 mM NaCl, 10% glycerol (v/v), 0.1% DDM (w/v), 0.01% CHS (w/v)) and
NTS1 was eluted in a small volume with 400 mM imidazole.
The eluate was labelled with either (1) Alexa Fluor 488 (A488)/Alexa Fluor 555
(A555, Life Technologies), (2) Cy3/Cy5 (GE Healthcare), or (3) (1-oxyl-2,2,5,5-
tetramethylpyrroline-3-methyl)-methanethiosulfonate (MTSL, Toronto Research
Chemicals), for ensemble FRET, smFRET, or DEER experiments, respectively.
Labelling was performed by incubation of NTS1 with a 2–20 times molar excess of
label for 5–60 min at room temperature. Excess label was removed by gel ﬁltration
(2–3.5 mL HiTrap Desalt columns, GE Healthcare, connected in series, or Zeba
Spin Desalting Columns, MWCO 40 K, Pierce, Thermo Scientiﬁc), simultaneously
buffer exchanging the receptor into 50 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM
EDTA, 0.1% (w/v) DDM, 0.01% (w/v) CHS, and 10% (v/v) glycerol.
The average labelling efﬁciency of the ﬂuorophore-labelled samples was
determined by comparing the absorption at 280 nm with that of the ﬂuorophore
maximum, correcting for the contribution of the ﬂuorophore at 280 nm
Elabelling ¼ Label½ NTS1½  ¼
Alabel=εlabel
A280  CF ´ALabelð Þ=εNTS1 ð1Þ
where ALabel and A280 are the maximum absorption of the ﬂuorophore and the
absorption at 280 nm, respectively, εLabel the extinction coefﬁcient of the
ﬂuorophore at its maximum, and εNTS1 that of NTS1 at 280 nm (56,840M−1 cm
−1). CF is a correction factor to account for the contribution of the ﬂuorophore at
280 nm which is determined from the excitation spectrum of the free ﬂuorophore
in solution as the percentage absorption at 280 nm compared to its maximum
absorption. For DEER and ensemble FRET measurements, NTS1 was reconstituted
in brain polar lipid (BPL, Avanti polar lipids) liposomes, using Bio-Beads (Bio-
Rad) for detergent removal21. Speciﬁcally, BPL in chloroform was dried down to a
lipid ﬁlm using a rotary evaporator and further dried overnight in a desiccator
under vacuum and stored at 20 °C. The lipid ﬁlm was suspended in liposome buffer
(50 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, saturated with N2) to give a
ﬁnal concentration of 5 mgmL−1, and sonicated (3 × 1 min) using a bath sonicator,
followed by ten freeze-thaw cycles using liquid nitrogen and a 37 °C water bath.
The liposomes were then extruded through a 100 nm polycarbonate ﬁlter using a
mini-extruder, for at least 11 passes to obtain a homogeneous distribution of
liposomes of 100 nm in diameter. DDM was added to the lipid suspension at a ﬁnal
concentration of 0.25% (w/v) and the lipids were gently stirred for 1–3 h. The
detergent-liposome mix was then added to the receptor at the desired lipid-to-
protein ratio, and incubated for 1 h at 4 °C. Bio-Beads were washed with methanol,
followed by MilliQ water, and equilibrated with liposome buffer, and then added at
0.3 g mL−1 (wet weight) and the sample was left to incubate overnight on a rotating
wheel at 4 °C. Bio-Beads were then removed, and proteoliposomes were harvested
by centrifugation (~100,000 g, 3 h, 4 °C). For FRET experiments donor and
acceptor-labelled NTS1 was reconstituted together at a 1:1 molar ratio, as well as
separately for donor-only, and acceptor-only controls. Initial lipid-to-protein ratios
of 1:6000, 1:12,000, and 1:1500 (mol:mol) were used for FRET, donor/acceptor-
only FRET control, and DEER samples, respectively. Final lipid-to-protein ratio
was determined by sucrose density gradient centrifugation (see Supplementary
Note 10 and Supplementary Table 6).
Droplet interface bilayer single-molecule FRET experiments. Droplet interface
bilayers (DIBs) are formed following the self-assembly of lipid monolayers at
water–oil interfaces, with subsequent contacting of two such interfaces giving rise
to a bilayer27. Here, a solution of lipid in oil is placed on top of a hydrogel and
allowed to equilibrate. An aqueous droplet is then introduced in this solution and
allowed to come into contact with the hydrogel surface. A lipid bilayer sponta-
neously forms at the interface between the two aqueous phases. Protein inserts into
the bilayer following the incorporation of detergent puriﬁed NTS1 in the aqueous
droplet. The planar nature of DIBs formed on a thin (<100 nm) hydrogel layer
make them amenable to single-molecule imaging via TIRF microscopy (Supple-
mentary Fig. 1). Hydration of the underlying agarose layer enables free diffusion of
membrane components57. DIBs were prepared following previously reported
methodologies27. Brieﬂy, molten agarose in water (0.75% w/v, 90 °C) was spin-
coated (3000 rpm, 30 s, using a Laurell Technologies Corporation spin coater) on
top of a O2 plasma-cleaned glass coverslip prior to incorporation of the coverslip
into a poly(methyl methacrylate) (PMMA) micro-device. The agarose-coated
coverslip forms the optically accessible base layer upon which the DIB is formed.
The micro-machined PMMA device comprises a planar ﬂuidic channel in contact
with the underlying agarose-coated coverslip; this channel interdigitates an array of
vertical open wells allowing access to the spin-coated agarose layer from the top of
the device. A molten solution of agarose (1.8% w/v, 90 °C) in 50 mM NaCl, 1 mM
EDTA, 50 mM Tris-HCl at pH 7.4 is pipetted into the ﬂuidic channel such that the
agarose ﬁlls the full volume of the channel, contacting the underlying spin-coated
agarose, providing a source of hydration to the low-volume spin-coated agarose
layer. The rehydrating agarose does not enter the wells of the device, maintaining
an accessible area of suitably thin, yet hydrated, agarose for evanescent ﬁeld
penetration in subsequent TIRF imaging. The agarose layer within each
well was submerged in oil solution (hexadecane:silicone oil AR20 (19:1))
containing dissolved lipid (1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC)
8 mgmL−1) and allowed to equilibrate for 15 min. A ~0.02 μL aqueous droplet (50
mM NaCl, 1 mM EDTA, 50 mM Tris-HCl at pH 7.4) containing Cy3 and Cy5
labelled NTS1 T186C4.42 (provided from protein preparations at 0.15 μM (Cy3)
and 0.18 μM (Cy5) in 50 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl at pH 7.4 with
0.1% (w/v) DDM, 0.01% (w/v) CHS, 10% (v/v) glycerol, added immediately prior
to droplet preparation), was incubated in a separate chamber containing the same
lipid in oil solution for 20–25 minutes before being transferred by pipette to the
experimental device. Bilayer formation proceeded upon the droplet sinking to the
bottom of the oil-containing well and contacting the underlying agarose surface.
NTS1 was incorporated in the droplet at a total concentration of 550 pM with a
labelling ratio of 100:405:45 Cy3:Cy5:unlabelled. This concentration ratio ensured a
greater prevalence of FRET capable dimerisation compared to equimolar labelling
conditions, affording the measurement of an increased number of dimers, whilst
retaining single-molecule resolution in both donor and acceptor channels. Unla-
belled receptor was present as a consequence of incomplete labelling of the
acceptor population (10% unlabelled). This was accounted for in all subsequent
calculations (see Supplementary Information).
Microscopy. A 532 nm laser (LDC-1500, Suwtech, Saxonburg PA, USA) was
expanded to a collimated beam diameter of 2 mm before focussing off-axis at the
back aperture of a TIRF oil immersion objective lens (60 × Plan Apo N.A. 1.4,
Nikon Instruments, UK) mounted on an inverted microscope (Ti Eclipse, Nikon
Instruments, UK), giving rise to total internal reﬂection illumination at the cov-
erslip surface. Emitted ﬂuorescence was collected through the same objective,
transmitted through a dichroic mirror (Nikon532 C67195) prior to passing
through a long pass emission ﬁlter (532 nm EdgeBasic BLP01-532R-25 Semrock,
USA) followed by wavelength image splitting to separate out donor and acceptor
emission for side-by-side imaging on a single 128 × 128 pixel frame-transfer
emCCD detector (iXon DU-860, Andor Technology PLC, Belfast, UK). Wave-
length image splitting was achieved with a Optosplit II (Cairn Research, UK) with
a dichroic beamsplitter (640 nm FF640-FDi01 Semrock, USA) followed by band-
pass ﬁlters in each channel (582/75 (FF01-582/75-25 Semrock, USA) and 670/40
(670DF40 Omega Optical, USA)), selected to minimise donor and acceptor
emission bleed, with focal parity achieved via a correction lens in the red channel.
Images were acquired with a frame time of 30 ms and EM gain of 255 and saved as
16-bit Tagged Image File Format (TIFF) for subsequent analysis. A beam shutter
TTL synchronised to the emCCD ensured ﬂuorophore labelled protein experienced
no laser exposure prior to image acquisition to avoid photobleaching. Data were
acquired from ﬁve droplet interface bilayers. Multiple time series acquisitions of 6 s
were recorded for each bilayer, with each acquisition in a previously unexposed
area of the bilayer. Due to the variability in reconstitution efﬁciency between
bilayers58 (Supplementary Fig. 4) and the concentration dependency of dimerisa-
tion, only bilayers with a Cy3 (donor) receptor density above 0.04 μm−2 were
considered for further analysis. In the case of NST1 dimerisation, a total of 19
videos were analysed containing 17,853 donor trajectories, comprising
209,712 spots, and 1167 acceptor trajectories, comprising 8561 spots. For
the doubly labelled NTS1 construct (A90C1.58-T186C4.42 labelled with Cy3 and
Cy5), smFRET experiments were conducted at a reduced receptor concentration to
ensure a predominantly monomeric receptor population; 371 acceptor trajectories,
comprising 2816 spots were measured.
smFRET image analysis. All data were analysed using ImageJ and Matlab
(R2012a) (MathWorks USA). Image stacks were prepared for spot detection and
tracking in ImageJ. Background subtraction was performed via the pixel-wise
subtraction of time averaged median pixel intensity from each image sequence.
Image stacks were subsequently split into donor and acceptor channel images
(64 × 128 pixels) with spot detection and particle tracking conducted on each stack
using the ImageJ plugin trackmate59, included in the FIJI distribution of ImageJ.
For spot detection an estimated spot size diameter of 3 pixels was employed, with
detection following a difference of Gaussians algorithm (DoG) calculating the
difference image between two Gaussian smoothed images. This process serves as a
bandpass ﬁlter removing high spatial frequency noise whilst preserving spatial
features on the order of the estimated diffraction-limited spot of a single ﬂuor-
ophore to aid spot detection. Trajectory linking was performed with a maximum
linking distance of 5 pixels, a maximum gap-closing distance of 5 pixels at a
maximum gap-closing frame gap of two frames. A minimum track length cut-off of
three frames was subsequently employed to ensure the acceptance of only bona ﬁde
receptor trajectories, excluding any false-positive spot detections. Trajectories were
subsequently analysed in Matlab. An image of the TIRF illumination spot following
smoothing with a Gaussian blur (σ= 10 pixels) was used to create an x/y lookup of
relative laser illumination intensity to normalise trajectory spot intensity in
accordance with the spot position in the TIR illumination area. Mean square
displacement and diffusion coefﬁcient of donor and acceptor trajectories was cal-
culated in Matlab following previously reported routines60. For the extraction of
smFRET efﬁciencies (E) and the generation of two colour single-spot excised dimer
trajectories, donor and acceptor video pairs were individually registered and
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overlaid as separate colour channels. Spot detection and tracking was performed on
combined images. 40 trajectories lasting longer than 0.5 s and free from spot-
crowding in the donor channel (in order to increase reliability of donor spot
intensity extraction) were taken forward for the frame-by-frame extraction of
smFRET efﬁciency traces. x/y/t spot trajectory data were used to excise regions of
interest from the respective donor and acceptor stacks accounting for image
registration offset. Spot ﬁtting and intensity extraction proceeded with 2D Gaussian
ﬁtting on the excised donor and acceptor image sub-stacks, respectively.
Excised regions of donor and acceptor channels were recombined to create
two colour single spot image stacks of FRET dimer trajectories, as illustrated in
Fig. 4a. Although sub-pixel resolution was employed for calculating image
registration offset and deﬁning spot location, recombined images were simply
registered to the nearest pixel, to avoid interpolation and preserve imaging data as
acquired.
smFRET intensity distribution analysis. Gaussian mixture models were ﬁtted to
the logarithm of the single-molecule intensity data for (a) the FRET acceptor
intensity of dimeric species; (b) the FRET acceptor intensity of doubly labelled,
FRET capable, monomeric protein (control 1); and (c) the direct donor excitation
of monomeric singly labelled receptor (control 2), using the Mclust package for
R61. To account for differences in sample size between the intensity distributions
for the three data sets, the data were bootstrapped 1000 times, taking random
samples of n= 1000 for each of the three data sets. Four Gaussian mixture models
composed of 1–4 components were ﬁtted to each bootstrapped data sample, and
the corresponding Bayesian information criterion (BIC) value was calculated to
assess the relative likelihood of each of the models. To compare between boot-
strapped samples, the BIC values for each sample were converted to BIC difference
values by subtracting the largest BIC in the set (BICi,j−BICi,max).
Monte Carlo simulations. Two-dimensional Monte Carlo simulations simulating
receptor diffusion, dimerisation, and dissociation were coded in Matlab, para-
meterised by the kinetic parameters determined by single-molecule DIB experi-
ments. Monomeric receptors were described as point-like particles with a collision
radius, r, diffusing randomly on a 2D surface with diffusion coefﬁcient, Dmon.
These properties were used to determine the time step (dT). This was deﬁned as the
time period in which under Brownian diffusion a receptor would be expected on
average to diffuse a distance equivalent to half a receptor radius. Particle number,
surface density and nominal labelling proportion were deﬁned by the user to enable
simulation of different experimental conditions. The combined prescribed particle
number and density deﬁned the area of the square surface on which the particle
diffusion was simulated. 2D periodic boundary conditions were implemented such
that the simulated experimental surface approximated a boundary-less continuous
surface at the described particle density. Following Einstein’s relation, diffusive
displacement was assumed to follow a Gaussian probability distribution function
with standard deviation given by
σ ¼ ð2DmondTÞ0:5 ð2Þ
At each time step the random diffusion of each particle was determined in turn
by a random-normally distributed step-size, determined by the particle diffusion
coefﬁcient with normal distribution described by Eq. 2. The direction of this step
was determined by a randomly assigned angle between 0 and 360 degrees. Particle
locations were deﬁned with a tolerance of 10−5. Within a single time step of the
simulation each particle was moved sequentially before checking for particle
collisions. Collisions were detected by determining the separation between all
particles. All particle pairs separated by a distance of equal to, or less than, a
receptor collision radius (twice receptor radius) were identiﬁed as collisions.
Collisions were then determined to proceed to particle dimers with a probability
(p) described by the estimation based on experimental data using the method
described by Hardt30 (see Supplementary Note 3). Dimer particles diffused with a
diffusion coefﬁcient, Ddim, as measured experimentally, and could dissociate with a
probability determined by koff and the duration of the simulation time step.
Higher-order oligomers were precluded. Dimer particles maintained their
constituent receptors particle identities. Consequently all particles could be
categorised by label identity for simulated FRET experiments, where simulated
donor and acceptor channel images were generated at 30 ms intervals. Simulations
were initiated out of equilibrium with all particles initially described as monomers.
Monomer and dimer populations were monitored over time. Dynamic equilibrium
was established within 5000 steps in all cases as determined by analysis of a rolling
average spanning different time windows for simulations of durations of up to 200
s. For collection of the data in Fig. 3c, 300 particles were simulated at a range of
receptor densities spanning the single-molecule, physiological, and ensemble
experimental range. A period of 50 s was simulated and simulations run three times
at each receptor density. Monomer:dimer population was measured under dynamic
equilibrium conditions in each simulation using all time points from the 5001st
step onward.
Ensemble FRET. NTS1 proteoliposomes (containing 0.15–0.2 nmol receptor) were
pelleted (100,000 g, 3 h, 4 °C) and resuspended in 150–200 μL of detergent-free
buffer (50 mM Tris-HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol),
yielding a ﬁnal concentration of ~1 μM. Fluorescence emission spectra were
recorded at room temperature on a Perkin-Elmer LS-50B ﬂuorimeter (slit widths
4.5 nm for excitation and 5 nm for emission, to optimise the signal-to-noise ratio).
A background sample consisting of empty liposomes was used to correct for any
background ﬂuorescence and scattering effects. Spectra were smoothed using
Savitzky-Golay ﬁltering (10 nm window, second order polynomial) using Origi-
nPro 8.5 to minimise noise artefacts in the determination of spectral maxima.
Apparent FRET efﬁciencies were determined as described in Supplementary
Note 9. The resulting apparent FRET efﬁciency (Eapp) was further corrected for the
donor-to-acceptor ratio (rDA), determined from the ﬂuorescence emission spectra,
correcting for quenching of the donor emission due to FRET as described by
Gordon et al.62
FD ¼ Fem:Dex:D þ FFRET;cor
ΦD
ΦA
ð3Þ
where Fem:Dex:D is the emission spectrum of the donor in the mixed FRET sample
when excited at the donor wavelength, FFRET;cor the FRET signal corrected for
bleedthrough and crosstalk as described by Goddard et al.63, and ΦD and ΦA the
ﬂuorescence quantum yield of the donor and acceptor ﬂuorophores, respectively,
which were taken to be 0.92 and 0.10, respectively, as speciﬁed by the supplier. As
the ﬂuorescence emission is proportional to the sample concentration, multiplied
by the quantum yield and the extinction coefﬁcient, the donor-to-acceptor ratio
rDA can be calculated using
rDA ¼ FDFA
ΦAεA
ΦDεD
ð4Þ
where FA is the emission of acceptor in the mixed FRET sample, upon excitation at the
acceptor maximum. The corrected FRET efﬁciency Ecor is calculated from Eapp and rDA
Ecor ¼ Eapp 1þ rDArDA ð5Þ
as derived by Bykova and Zheng64, assuming random association of donor- and
acceptor-labelled NTS1. This correction accounts for the dimerisation of like
ﬂuorophore-tagged receptors (i.e., NTS1-A488-NTS1-A488 and NTS1-A555-
NTS1-A555 dimers), which leads to an underestimation of the FRET efﬁciency.
The corrected FRET efﬁciencies from multiple FRET samples were then averaged,
and subjected to statistical analysis using R (RStudio, Inc.) using a Bayesian
alternative to the two-sample t-test, BEST65.
DEER. NTS1 proteoliposomes (containing 5–10 nmol receptor) were pelleted
(100,000 g, 3 h, 4 °C) and resuspended in ~10 μL of detergent-free buffer (50 mM
Tris-HCl pH 7.4, 50 mM NaCl, 1 mM EDTA, 30% (v/v) deuterated glycerol),
yielding a ﬁnal concentration of ~100–200 μM. Samples were loaded into 1.6 mm
(outer diameter) quartz tubes (Wilmad-LabGlass) and ﬂash-frozen in liquid
nitrogen. The background dimensionality was determined to be 2.3 from control
experiments with MTSL-labelled NTS1 (S172C) reconstituted together with unla-
belled receptor at a 1:3 molar ratio. DEER traces (using 3- and 4-pulse PELDOR
sequences) were recorded at 50 K at Q-band on an ELEXYS E580 equipped a
SuperQ-FT bridge (Bruker) with 2 mm split-ring resonator (EN-5107D2, Bruker).
Resulting 3- and 4-pulse DEER traces were phase-corrected using DeerAnalysis
201366, and then stitched together using MATLAB 2013 (MathWorks) by least-
squares ﬁtting as per the DEER-Stitch method67,68. Distance distributions were
derived from stitched data using DeerAnalysis 2013.
Modelling of dimer interface. A wild-type (wt-)NTS1 model was built from the
crystal structure of the NTS1 thermostabilised mutant (PDB code 4BUO, chain
B26) by back-mutating it to its native sequence, followed by minimisation and
optimisation of the hydrogen bond network around 4 Å of the back-mutated
residues, using MOE69. Putative parallel GPCR dimerisation interfaces were
identiﬁed from a thorough analysis of all GPCR crystal structures deposited in the
Protein Data Bank to date; structures of the ß1 adrenergic (ß1AR, PDB 4GPO32),
CXC chemokine type 4 (CXCR4, PDB 3OE035), histamine 1 (H1R, PDB 3RZE34),
κ-opioid (κOR, PDB 4DJH36) and µ-opioid (µOR, PDB 4DKL33) receptors were
employed as templates for the construction of structural NTS1 dimer models in
combination with the wt-NTS1 model. The speciﬁed NTS1 monomer crystal
structure (PBD 4BUO26) was prioritised as a modelling template because it does
not contain a fusion protein included in other crystallised NTS1 constructs (PDB
4GRV, 4XEE, 4XES, 5T04)25,70,71, has an intact helix 8, and was solved to higher
resolution than other thermostabilised NTS1 structures lacking fusion proteins
(PDB 3ZEV, 4BVO, 4BWB)26. Seven different structural dimer models were
constructed using Modeller72, representing four different classes of dimerisation
interfaces comprising of (1) TM1-2-H8 (ß1AR, κOR and µOR); (2) TM3-4 (H1R);
(3) TM3-4-5 (CXCR4 and ß1AR); and (4) TM5-6 (µOR)32–36. The best DOPEHR-
scored73 solution of each model was used for subsequent MD simulations.
Molecular dynamics simulations. Using the CHARMM-GUI Martini webser-
ver74, the seven dimer models were converted to coarse grained (CG) repre-
sentation and embedded in a BPL mimicking membrane composed of POPC:
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POPS:POPE:cholesterol (15:22:39:24), and solvated in the presence of 150 mM
NaCl. The force ﬁeld Martini 2.275 was employed and, after careful equilibration,
10 µs of production CG MD trajectory was reached. The ﬁrst microsecond of
simulation was considered part of the equilibration so it was not considered for
analysis. The protein CG beads of the remaining 9 µs were converted to atomistic
(AT) representation40 at 1 ns intervals, giving rise to 9000 frames of AT trajectory.
Dimer interface analysis. MD-derived models were compared to the experimental
ensemble FRET data. For each of the converted CG-to-AT frames, the intradimer
Cß–Cß distances between carbons at the positions labelled in the FRET experiments (of
alike transmembrane domains, i.e., TM1–TM1, TM2–TM2, etc.) were measured. These
MD-derived Cß–Cß distances (R) were converted to FRET efﬁciencies (EFRET) using the
relation EFRET= ((R06)/(R06+R6)), and the literature value of R0= 7.0 nm for the
Förster radius of the A488–A555 donor and acceptor pair31.
These estimated FRET efﬁciencies for all label sites for each model were then
compared to the experimental ensemble FRET efﬁciencies; the resulting average FRET
efﬁciency from all 127 possible linear combinations of these models, varying the
number of included models from one to seven, were tested against the experimental
data. Speciﬁcally, a vector M with eight elements, where each element represents the
estimated intradimer FRET efﬁciency for each of the labelling positions, was created
for each linear combination of models by (element-wise) summation of the vectors for
the individual models, Mi, multiplied by a coefﬁcient, ci, which gives the fractional
contribution of the model, i.e.,
P
i ciMi , where i varies from one to seven
(representing the seven different dimer interface models built) and
P
i ci ¼ 1. Using
the quadprog optimisation package for R in RStudio, the optimal values for the
coefﬁcients ci were determined to minimise the residual sum of squares (RSS) between
the elements of M and the equivalent eight-element vector containing the
experimental FRET efﬁciencies. The Akaike information criterion (AIC) value for
each model ﬁt was used to assess the relative likelihood of the different models. An F-
test was used to test the statistical signiﬁcance of the difference between ﬁts of the
FRET data collected in the absence or presence of agonist. The combinatorial models
with the lowest RSS and AICs were then selected for further analysis.
Theoretical DEER distance distributions were generated using MMM (with the
MTSL rotamer library at 175 K)76 for the NTS1 dimer models with dimer
interfaces TM1–2–H8 based on ß1AR, TM3–4 based on H1R, and TM5–6 based
on µOR for ten snapshots of the MD simulations for each model, which were then
averaged for each model. Using the same approach as for the bulk FRET data, the
calculated distance distributions for the three models and their linear combinations
were ﬁtted to the experimental DEER data, where the AIC values were used to
assess the relative likelihood of the different models.
Data availability. Data and code supporting the ﬁndings of this manuscript are
available from the corresponding authors upon reasonable request.
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